← Back to Vaccine Database

MVA-SARS-2-S

Viral vector (Non-replicating) vaccine · VDDBV0537

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04569383 Phase 1COVID-19
NCT05226390 Phase 1COVID-19